Detalhe da pesquisa
1.
A Risk Profile Using Simple Hematologic Parameters to Assess Benefits From Baricitinib in Patients Hospitalized With COVID-19: A Post Hoc Analysis of the Adaptive COVID-19 Treatment Trial-2.
Ann Intern Med
; 177(3): 343-352, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38408357
2.
SARS-CoV-2 RNA and nucleocapsid antigen are blood biomarkers associated with severe disease outcomes that improve in response to remdesivir.
J Infect Dis
; 2024 Apr 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-38657001
3.
Temporal Improvements in COVID-19 Outcomes for Hospitalized Adults: A Post Hoc Observational Study of Remdesivir Group Participants in the Adaptive COVID-19 Treatment Trial.
Ann Intern Med
; 175(12): 1716-1727, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36442063
4.
Are Some COVID-19 Vaccines Better Than Others? Interpreting and Comparing Estimates of Efficacy in Vaccine Trials.
Clin Infect Dis
; 74(2): 352-358, 2022 01 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-33693552
5.
Remdesivir for the Prevention of Invasive Mechanical Ventilation or Death in Coronavirus Disease 2019 (COVID-19): A Post Hoc Analysis of the Adaptive COVID-19 Treatment Trial-1 Cohort Data.
Clin Infect Dis
; 74(7): 1260-1264, 2022 04 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34379740
6.
CD4+ T Cell Regulation of Antibodies Cross-Reactive with Fungal Cell Wall-Associated Carbohydrates after Pneumocystis murina Infection.
Infect Immun
; 87(7)2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31010812
7.
The Brief Case: Streptococcus intermedius Brain Abscesses in an Otherwise Healthy Young Man Diagnosed by 16S rRNA Gene Sequencing.
J Clin Microbiol
; 60(1): e0197020, 2022 01 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-35045273
8.
Efficacy and immunogenicity following dengue virus-1 human challenge after a tetravalent prime-boost dengue vaccine regimen: an open-label, phase 1 trial.
Lancet Infect Dis
; 2024 Apr 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-38679035
9.
Baricitinib Treatment of Coronavirus Disease 2019 Is Associated With a Reduction in Secondary Infections.
Open Forum Infect Dis
; 10(5): ofad205, 2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-37206623
10.
Role of interleukin-23-dependent antifungal immune responses in dendritic cell-vaccinated mice.
Infect Immun
; 79(9): 3778-83, 2011 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-21746859
11.
Using Adjuvants to Drive T Cell Responses for Next-Generation Infectious Disease Vaccines.
Vaccines (Basel)
; 9(8)2021 Jul 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-34451945
12.
Human Salmonella Typhi exposure generates differential multifunctional cross-reactive T-cell memory responses against Salmonella Paratyphi and invasive nontyphoidal Salmonella.
Clin Transl Immunology
; 9(9): e1178, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33005416
13.
Pathogenesis of allergic bronchopulmonary aspergillosis in cystic fibrosis: current understanding and future directions.
Med Mycol
; 47 Suppl 1: S331-7, 2009.
Artigo
em Inglês
| MEDLINE | ID: mdl-18668399
14.
CD4+ T cell-independent DNA vaccination against opportunistic infections.
J Clin Invest
; 115(12): 3536-44, 2005 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-16308571
15.
Immune reconstitution inflammatory syndrome associated with pulmonary pathogens.
Eur Respir Rev
; 26(143)2017 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-28049128
16.
An Immunocompromised Woman with a Brain Lesion.
Am J Med
; 133(9): e516-e517, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32199814
17.
Bigger Foot: Kaposi's Sarcoma.
Am J Med
; 128(9): 959-62, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-26055548
18.
Conserved natural IgM antibodies mediate innate and adaptive immunity against the opportunistic fungus Pneumocystis murina.
J Exp Med
; 207(13): 2907-19, 2010 Dec 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-21149550
19.
Corrigendum. CD4+ T cell-independent DNA vaccination against opportunistic infections.
J Clin Invest
; 125(3): 1364, 2015 Mar 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-25729856
20.
Dectin-1 Fc targeting of aspergillus fumigatus beta-glucans augments innate defense against invasive pulmonary aspergillosis.
Antimicrob Agents Chemother
; 52(3): 1171-2, 2008 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-18086835